Puma Biotechnology, Inc. (PBYI)
10.29
+0.32
(+3.21%)
USD |
NASDAQ |
Oct 09, 16:00
10.29
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Free Cash Flow : 41.16M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.16M |
| March 31, 2026 | 53.60M |
| December 31, 2025 | 41.73M |
| September 30, 2025 | 42.87M |
| June 30, 2025 | 44.22M |
| March 31, 2025 | 31.17M |
| December 31, 2024 | 38.86M |
| September 30, 2024 | 33.68M |
| June 30, 2024 | 33.25M |
| March 31, 2024 | 35.47M |
| December 31, 2023 | 14.37M |
| September 30, 2023 | 11.64M |
| June 30, 2023 | 18.31M |
| March 31, 2023 | 1.211M |
| December 31, 2022 | -15.83M |
| September 30, 2022 | -28.94M |
| June 30, 2022 | -35.71M |
| March 31, 2022 | -21.91M |
| December 31, 2021 | 20.65M |
| September 30, 2021 | 10.43M |
| June 30, 2021 | 1.638M |
| March 31, 2021 | 7.928M |
| December 31, 2020 | -19.27M |
| September 30, 2020 | -2.355M |
| June 30, 2020 | -11.37M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.66M |
| December 31, 2019 | 22.07M |
| September 30, 2019 | 27.80M |
| June 30, 2019 | 27.54M |
| March 31, 2019 | -34.55M |
| December 31, 2018 | -24.71M |
| September 30, 2018 | -117.46M |
| June 30, 2018 | -164.95M |
| March 31, 2018 | -193.03M |
| December 31, 2017 | -222.90M |
| September 30, 2017 | -178.66M |
| June 30, 2017 | -158.56M |
| March 31, 2017 | -150.07M |
| December 31, 2016 | -148.97M |
| September 30, 2016 | -140.55M |
| June 30, 2016 | -142.61M |
| March 31, 2016 | -140.08M |
| December 31, 2015 | -155.65M |
| September 30, 2015 | -141.65M |
| June 30, 2015 | -129.08M |
| March 31, 2015 | -111.87M |
| December 31, 2014 | -78.50M |
| September 30, 2014 | -73.18M |
| June 30, 2014 | -60.82M |
| March 31, 2014 | -54.27M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arcutis Biotherapeutics, Inc. | 39.15M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Savara, Inc. | -110.66M |
| Vericel Corp. | 61.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.624M |
| Cash from Investing (Quarterly) | 7.972M |
| Cash from Financing (Quarterly) | -11.34M |
| Free Cash Flow Per Share (Quarterly) | 0.0309 |
| Free Cash Flow to Equity (Quarterly) | 12.76M |
| Free Cash Flow to Firm (Quarterly) | 1.803M |
| Free Cash Flow Yield | 7.77% |